2-Propenoic acid, 3-[4'-[2-(hydroxyamino)-2-oxoethoxy]-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl]-, (2E)-
- CAS No.
- 2217671-64-0
- Chemical Name:
- 2-Propenoic acid, 3-[4'-[2-(hydroxyamino)-2-oxoethoxy]-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl]-, (2E)-
- Synonyms
- MIR002;2-Propenoic acid, 3-[4'-[2-(hydroxyamino)-2-oxoethoxy]-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl]-, (2E)-
- CBNumber:
- CB212619702
- Molecular Formula:
- C27H29NO5
- Molecular Weight:
- 447.52
- MDL Number:
- MOL File:
- 2217671-64-0.mol
- MSDS File:
- SDS
2-Propenoic acid, 3-[4'-[2-(hydroxyamino)-2-oxoethoxy]-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl]-, (2E)- price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0435026 | MIR002 99.0% | 2217671-64-0 | 5mg | $390 | 2026-06-04 | Buy |
| ChemScene | CS-0435026 | MIR002 99.0% | 2217671-64-0 | 10mg | $639 | 2026-06-04 | Buy |
| ChemScene | CS-0435026 | MIR002 99.0% | 2217671-64-0 | 25mg | $1278 | 2026-06-04 | Buy |
| ChemScene | CS-0435026 | MIR002 99.0% | 2217671-64-0 | 50mg | $2058 | 2026-06-04 | Buy |
| ChemScene | CS-0435026 | MIR002 99.0% | 2217671-64-0 | 100mg | $3358 | 2026-06-04 | Buy |
2-Propenoic acid, 3-[4'-[2-(hydroxyamino)-2-oxoethoxy]-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl]-, (2E)- Chemical Properties, Uses, Production
Uses
MIR002 is a potent and orally active DNA polymerase α (POLA1) and HDAC 11 dual inhibitor. MIR002 induces acetylation of p53, activation of p21, G1/S cell cycle arrest, and apoptosis. MIR002 shows significant antitumor activity in vivo[1].
in vivo
MIR002 (50 mg/kg; p.o.; twice a day for 5 days a week, 3 weeks) shows a good tolerability and antitumor activity (TGI=61%)[1].
MIR002 (50 mg/kg; p.o.; twice a day for 5 days a week, 6 weeks) shows an additive antitumor effect with complete disappearance of tumor masses in two animals at the end of the treatment when combination with cisplatin[1].
MIR002 ( 50 mg/kg, twice a day for 5 days) induces a significant increase of a interferon at its pharmacological active dose (50 mg/kg)[1].
| Animal Model: | Model: 4-6 weeks old female CD-1 nude mice (NSCLC NCI-H460 model) |
| Dosage: | 50 mg/kg |
| Administration: | p.o.; twice a day for 5 days a week, 3 weeks |
| Result: | Showed a good tolerability and antitumor activity (TGI=61%). |
| Animal Model: | 4-6 weeks old female CD-1 nude mice ( MM473-luc and MM487-Luc)[1] |
| Dosage: | 50 mg/kg combibnated with cisplatin (i.p.; 5 mg/kg; twice a day for 7 days a week, 6 weeks) |
| Administration: | p.o.; twice a day for 5 days a week, 6 weeks |
| Result: | Showed an additive antitumor effect with complete disappearance of tumor masses in two animals at the end of the treatment when combination with cisplatin. |
| Animal Model: | 4-6 weeks old female CD-1 nude mice (Melanoma B16 model)[1] |
| Dosage: | 50 mg/kg |
| Administration: | p.o.; twice a day for 5 days |
| Result: | Induced a significant increase of α interferon at its pharmacological active dose (50 mg/kg). |
IC 50
HDAC11: 6.09 μM (IC50); POLA1
References
[1] Dallavalle S, et al. Antitumor activity of novel POLA1-HDAC11 dual inhibitors. Eur J Med Chem. 2022, 228:113971. DOI:10.1016/j.ejmech.2021.113971
2-Propenoic acid, 3-[4'-[2-(hydroxyamino)-2-oxoethoxy]-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl]-, (2E)- Preparation Products And Raw materials
Raw materials
Preparation Products
2-Propenoic acid, 3-[4'-[2-(hydroxyamino)-2-oxoethoxy]-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl]-, (2E)- Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Beckham Medical Technology Co., Ltd | 13816613772 | huahero21@sina.com | China | 2996 | 55 |
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 29874 | 58 |
| TargetMol Chemicals Inc. | 13564774135 | marketing@targetmol.com | United States | 19950 | 58 |
| Supplier | Advantage |
|---|---|
| Shanghai Beckham Medical Technology Co., Ltd | 55 |
| TargetMol Chemicals Inc. | 58 |
| TargetMol Chemicals Inc. | 58 |





